Infliximab (Anti–Tumor Necrosis Factor α Antibody)

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.2K citations · Full text

Pharmacy, Immunology, Inflammation +12

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

David Knight, Han Trinh, Junming Le et al. · Molecular Immunology · 1993 · 710 citations

Pharmacy, Immunology, Molecular Biology +14

Infliximab for the treatment of fistulas in patients with Crohn's disease

William J. Sandborn · Gastroenterology · 1999 · 523 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14